Feedback

Oxidized phospholipids are biomarkers, drug targets, and drug leads

Affiliation
Department of Pharmaceutical Chemistry ,Institute of Pharmaceutical Sciences ,University of Graz ,Graz ,Austria
Oskolkova, Olga V.;
Affiliation
Department of Medicine, University of Maryland School of Medicine ,Baltimore ,MD ,United States
Birukova, Anna A.;
Affiliation
Department of Medicine, University of Maryland School of Medicine ,Baltimore ,MD ,United States
Birukov, Konstantin G.;
Affiliation
Department of Pharmaceutical Chemistry ,Institute of Pharmaceutical Sciences ,University of Graz ,Graz ,Austria
Bochkov, Valery N.

Enzymatic oxidation or autooxidation of esterified polyunsaturated fatty acids (PUFA) residues within phospholipids in cell membranes or circulating lipoprotein particles leads to the formation of a broad range of oxidized phospholipid (OxPL) species. Chronically elevated OxPL levels present in circulation and atherosclerotic plaques are thought to induce proinflammatory and injurious effects on blood- and vessel wall cells. However, analysis of the structure-activity relationship also identified specific OxPL products exhibiting prominent anti-inflammatory, pro-survival and barrier protective properties. This minireview will briefly summarize rapidly accumulating evidence pointing to the importance of OxPLs in pathology, where they can play multiple roles of biomarkers, drug targets and drug leads.

Cite

Citation style:
Could not load citation form.

Access Statistic

Total:
Downloads:
Abtractviews:
Last 12 Month:
Downloads:
Abtractviews:

Rights

License Holder: Copyright © 2022 Oskolkova, Birukova, Birukov and Bochkov.

Use and reproduction: